Welcome to our blog community! This blog will show you how CED is helping emerging companies scale and grow in the Research Triangle Region. Plus we post news about our members and entrepreneurial resources.

Pages

Monday, November 29, 2010

NovaQuest Raises $177M and Operates as Separate Entity

NovaQuest, the former investment arm of Quintiles, has branched off from its former parent companyand is now operating as a separate entity. Quintiles, the Durham-based clinical research organization, launched NovaQuest in 2006. Although the two companies are now operating independently, Quintiles will remain a minority investor. NovaQuest is now its own Capital Management firm and has raised $177M of a targeted $500M fund. They invest heavily in early stage drug companies, but also work with large pharmaceutical companies and late stage trials. NovaQuest makes investments that range from around $1 M-$400M in its portfolio companies. The firm seeks to be part of an investment syndicate, instead of a lead investor, on most deals.

Quintiles has been a CED member since 1994 and sponsored our Biotech and Life Science conference last year. Quintiles and NovaQuest together employ about 1,400 individuals in the Triangle and are heavily influential in our community.

RSS/Atom Feeds

WRAL Tech Wire

NC Biotech News

Testimonial

“For the last 10 years CED has helped me to know what I need to know and to meet the people I need to meet. Every company has a different path to success, but in North Carolina all of those paths go through CED. Every entrepreneur - aspiring or experienced - needs vision, perseverance, and CED.” ~Michael Pollack, co-founder Advanced Liquid Logic